InChI=1S/C33H36O8/c1- 16(2)8-9-20-26-19(11-12-30(4,5)39-26)24(35)22-25(36)21-14-18-15-32(13-10-17(3)29(37)38)31(6,7)41-28(23(18)34)33(21,32)40-27(20)22/h8,10-12,14,18,28,35H,9,13,15H2,1-7H3,(H,37,38)/b17-10-/t18-,28+,32+,33+/m1/s1 |
| ITPZQGLNWWAFMF-FXQQNLISSA-N |
| [H][C@@]12C[C@@]3(C\C=C(\C)C(O)=O)C(C)(C)O[C@@]([H])(C1=O)[C@]31Oc3c(CC=C(C)C)c4OC(C)(C)C=Cc4c(O)c3C(=O)C1=C2 |
|
|
Garcinia morella
(IPNI:428103-1)
|
See:
DOI
|
|
Garcinia hanburyi
(NCBI:txid231906)
|
Found in
latex
(BTO:0000710).
Previous component: resin;
See:
PubMed
|
|
Garcinia hanburyi
(NCBI:txid231906)
|
Found in
fruit
(BTO:0000486).
See:
PubMed
|
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
|
antibacterial agent
A substance (or active part thereof) that kills or slows the growth of bacteria.
anti-HIV-1 agent
An anti-HIV agent that destroys or inhibits the replication of HIV-1, the more infective and more virulent of the two types of HIV virus.
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
|
(2Z)-4-[(1R,3aS,5S,14aS)-8-hydroxy-3,3,11,11-tetramethyl-13-(3-methylbut-2-en-1-yl)-7,15-dioxo-5,7-dihydro-3H,11H-1,5-methanofuro[3,4-g]pyrano[3,2-b]xanthen-3a(4H)-yl]-2-methylbut-2-enoic acid
|
|
15997152
|
PubMed citation
|
Europe PMC
|
|
17117343
|
PubMed citation
|
Europe PMC
|
|
20730041
|
PubMed citation
|
Europe PMC
|
|
21067206
|
PubMed citation
|
Europe PMC
|
|
8835458
|
PubMed citation
|
Europe PMC
|
|
